44.62
price down icon0.67%   -0.30
pre-market  プレマーケット:  44.66   0.04   +0.09%
loading
前日終値:
$44.92
開ける:
$45
24時間の取引高:
18.43M
Relative Volume:
0.90
時価総額:
$64.66B
収益:
$20.62B
当期純損益:
$3.56B
株価収益率:
18.71
EPS:
2.3847
ネットキャッシュフロー:
$3.48B
1週間 パフォーマンス:
+1.62%
1か月 パフォーマンス:
-11.42%
6か月 パフォーマンス:
-35.84%
1年 パフォーマンス:
-54.32%
1日の値動き範囲:
Value
$43.98
$45.74
1週間の範囲:
Value
$42.72
$45.74
52週間の値動き範囲:
Value
$42.20
$105.65

Boston Scientific Corp Stock (BSX) Company Profile

Name
名前
Boston Scientific Corp
Name
セクター
Healthcare (1065)
Name
電話
508-683-4000
Name
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
職員
59,000
Name
Twitter
@bostonsci
Name
次回の収益日
2026-10-28
Name
最新のSEC提出書
Name
BSX's Discussions on Twitter

Compare BSX vs ABT, MDT, SYK, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
BSX icon
BSX
Boston Scientific Corp
44.62 64.66B 20.62B 3.56B 3.48B 2.3847
ABT icon
ABT
Abbott Laboratories
103.49 179.08B 46.59B 5.41B 7.38B 3.0938
MDT icon
MDT
Medtronic Plc
89.30 114.23B 36.36B 4.84B 5.43B 3.7261
SYK icon
SYK
Stryker Corp
273.40 104.87B 25.27B 3.34B 4.57B 8.6334
EW icon
EW
Edwards Lifesciences Corp
86.82 50.04B 6.30B 1.07B 1.09B 1.8406

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-30 ダウングレード Raymond James Strong Buy → Outperform
2025-10-03 ダウングレード Erste Group Buy → Hold
2025-09-08 アップグレード Oppenheimer Perform → Outperform
2025-06-16 開始されました Leerink Partners Outperform
2025-04-16 アップグレード Needham Hold → Buy
2025-01-10 アップグレード Deutsche Bank Hold → Buy
2024-10-18 ダウングレード Needham Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-02-01 アップグレード Mizuho Neutral → Buy
2023-07-19 開始されました Robert W. Baird Outperform
2023-06-30 開始されました CL King Buy
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Buy
2022-12-22 開始されました Mizuho Neutral
2022-12-20 再開されました Citigroup Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-06 開始されました Wolfe Research Outperform
2022-05-27 アップグレード Needham Hold → Buy
2022-04-13 再開されました Truist Buy
2022-03-02 再開されました BofA Securities Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-05-26 ダウングレード Needham Buy → Hold
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Overweight
2020-09-17 開始されました Truist Buy
2020-09-11 開始されました Wolfe Research Peer Perform
2020-04-22 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-04-01 アップグレード Goldman Neutral → Buy
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Buy
2019-12-30 繰り返されました Cowen Outperform
2019-12-19 ダウングレード Needham Strong Buy → Buy
2019-09-05 再開されました JP Morgan Overweight
2019-09-03 再開されました Barclays Overweight
2019-05-13 アップグレード Evercore ISI In-line → Outperform
2018-11-28 開始されました UBS Buy
2018-10-16 開始されました Barclays Overweight
2018-10-02 繰り返されました Morgan Stanley Overweight
2018-09-07 繰り返されました Needham Strong Buy
2018-09-04 アップグレード Jefferies Hold → Buy
2018-07-06 繰り返されました Needham Strong Buy
2018-06-27 開始されました Bernstein Outperform
2018-04-26 繰り返されました Needham Strong Buy
すべてを表示

Boston Scientific Corp (BSX) 最新ニュース

pulisher
05:54 AM

Mexico Cardiac Rhythm Management Devices Market Outlook to 2036 Provides Revenue, Volume, Pricing and Competitive Insig - GlobeNewswire Inc.

05:54 AM
pulisher
05:44 AM

Wells Fargo Adjusts Price Target on Boston Scientific to $48 From $50, Keeps Equalweight Rating - marketscreener.com

05:44 AM
pulisher
01:27 AM

Boston Scientific stock slips before the bell after September 23 decline - AD HOC NEWS

01:27 AM
pulisher
Sep 23, 2026

Boston Scientific (BSX) Executive VP Arthur C. Butcher to Retire in January 2027 - GuruFocus

Sep 23, 2026
pulisher
Sep 23, 2026

Boston Scientific Corporation Announces Retirement of Arthur C. Butcher from Executive Vice President and Group President, Medsurg and Asia Pacific, Effective January 1, 2027 - marketscreener.com

Sep 23, 2026
pulisher
Sep 23, 2026

Boston Scientific announces retirement of executive vice president Arthur C. Butcher - Investing.com

Sep 23, 2026
pulisher
Sep 23, 2026

Form 8K Boston Scientific Corp For: 23 September By Investing.com - Investing.com Canada

Sep 23, 2026
pulisher
Sep 23, 2026

Form 8K Boston Scientific Corp For: 23 September - Investing.com India

Sep 23, 2026
pulisher
Sep 23, 2026

Arthur C. Butcher to Retire as Executive VP & Group President at Boston Scientific - TradingView

Sep 23, 2026
pulisher
Sep 22, 2026

Boston Scientific stock advances 2.1 percent ahead of the open - AD HOC NEWS

Sep 22, 2026
pulisher
Sep 22, 2026

Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch

Sep 22, 2026
pulisher
Sep 22, 2026

Boston Scientific re-evaluates 2027 framework after cyberattack - scanx.trade

Sep 22, 2026
pulisher
Sep 22, 2026

Boston Scientific stock holds near its yearly low after downgrade - AD HOC NEWS

Sep 22, 2026
pulisher
Sep 22, 2026

What Boston Scientific (BSX) Tells Us About the Healthcare Stocks Trade Right Now - Kalkine Media

Sep 22, 2026
pulisher
Sep 21, 2026

Boston Scientific stock heads into the open after a 0.9% gain - AD HOC NEWS

Sep 21, 2026
pulisher
Sep 21, 2026

Boston Scientific stock holds steady as Oppenheimer cuts price target to USD 65 - AD HOC NEWS

Sep 21, 2026
pulisher
Sep 21, 2026

Oppenheimer Adjusts Price Target on Boston Scientific to $65 From $85, Maintains Outperform Rating - marketscreener.com

Sep 21, 2026
pulisher
Sep 20, 2026

Boston Scientific stock holds steady as analysts weigh cyberattack impact - AD HOC NEWS

Sep 20, 2026
pulisher
Sep 18, 2026

Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure - MassDevice

Sep 18, 2026
pulisher
Sep 17, 2026

Boston Scientific Shares Fall After Citigroup Downgrade - marketscreener.com

Sep 17, 2026
pulisher
Sep 17, 2026

Citi downgrades Boston Scientific on uncertain recovery path - Investing.com

Sep 17, 2026
pulisher
Sep 17, 2026

Boston Scientific Can't Dislodge Rival's Heart Valve Patent - law360.com

Sep 17, 2026
pulisher
Sep 17, 2026

TD Cowen maintains Boston Scientific stock rating after cyberattack - Investing.com

Sep 17, 2026
pulisher
Sep 17, 2026

Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts PT to $50 From $57 - marketscreener.com

Sep 17, 2026
pulisher
Sep 15, 2026

Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

Sep 15, 2026
pulisher
Sep 15, 2026

Boston Scientific: A Great Company At A Deeply Discounted Price (Rating Upgrade) - Seeking Alpha

Sep 15, 2026
pulisher
Sep 14, 2026

Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga

Sep 14, 2026
pulisher
Sep 13, 2026

Boston Scientific Corp Share PriceBSX, RNS News, Articles, Quotes, & Charts (NYSE:BSX) - Proactive financial news

Sep 13, 2026
pulisher
Sep 13, 2026

Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance. - Yahoo Finance

Sep 13, 2026
pulisher
Sep 12, 2026

Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Stocktwits

Sep 12, 2026
pulisher
Sep 11, 2026

Boston Scientific stock falls as cyberattack clouds 2026 outlook - ad-hoc-news.de

Sep 11, 2026
pulisher
Sep 11, 2026

Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance

Sep 11, 2026
pulisher
Sep 11, 2026

Boston Scientific fully restores operations after cyberattack - Yahoo Finance

Sep 11, 2026
pulisher
Sep 11, 2026

What Is Moving the Story Around Boston Scientific (BSX)? - Kalkine Media

Sep 11, 2026
pulisher
Sep 10, 2026

Why Boston Scientific (BSX) Dipped More Than Broader Market Today - Yahoo Finance

Sep 10, 2026
pulisher
Sep 10, 2026

Boston Scientific Corp (BSX) Stock Down 4.1% -- Now Undervalued? GF Score: 77/100 - GuruFocus

Sep 10, 2026
pulisher
Sep 10, 2026

Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch

Sep 10, 2026
pulisher
Sep 10, 2026

Alpha Buying: 4 Falling Knives Insiders Are Buying - Benzinga

Sep 10, 2026
pulisher
Sep 10, 2026

Boston Scientific stock falls as cyberattack clouds 2026 guidance - ad-hoc-news.de

Sep 10, 2026
pulisher
Sep 10, 2026

Boston Scientific at Wells Fargo conference: cyberattack clouds outlook By Investing.com - Investing.com India

Sep 10, 2026
pulisher
Sep 10, 2026

Boston Scientific at Wells Fargo conference: cyberattack clouds outlook - Investing.com

Sep 10, 2026
pulisher
Sep 10, 2026

Boston Scientific Corp at Wells Fargo Healthcare Conference Transcript - GuruFocus

Sep 10, 2026
pulisher
Sep 09, 2026

Update on recent cybersecurity incident - Boston Scientific

Sep 09, 2026
pulisher
Sep 09, 2026

Boston Scientific stock falls as cyberattack prompts guidance cut and BTIG lowers price target - ad-hoc-news.de

Sep 09, 2026
pulisher
Sep 09, 2026

Boston Scientific Flags Financial Hit From Cyberattack - BankInfoSecurity

Sep 09, 2026
pulisher
Sep 09, 2026

Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga

Sep 09, 2026
pulisher
Sep 09, 2026

BSX Maintains Buy Rating by BTIG -- Price Target Lowered to $56 - GuruFocus

Sep 09, 2026
pulisher
Sep 09, 2026

Boston Scientific Corp. Stock Slides 5.9%, Underperforms Peers - webull.com

Sep 09, 2026
pulisher
Sep 09, 2026

Boston Scientific says cyberattack likely to hurt 2026 sales, profit By Reuters - investing.com

Sep 09, 2026
pulisher
Sep 08, 2026

Boston Scientific Corp (BSX) Stock Down 5.9% -- Now Undervalued? GF Score: 77/100 - GuruFocus

Sep 08, 2026
pulisher
Sep 08, 2026

Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack - theinsurer.com

Sep 08, 2026

Boston Scientific Corp (BSX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
EW EW
$86.82
price down icon 2.21%
$87.73
price down icon 2.01%
$66.09
price down icon 0.27%
SYK SYK
$273.40
price down icon 0.61%
PHG PHG
$24.45
price down icon 2.08%
大文字化:     |  ボリューム (24 時間):